Načítá se...
Matched cohort study on the efficacy of tocilizumab in patients with COVID-19
BACKGROUND: Tocilizumab has been proposed as a treatment for the new disease COVID-19, however, there is not enough scientific evidence to support this treatment. The objective of this study is to analyze whether the use of tocilizumab is associated with respiratory improvement and a shorter time to...
Uloženo v:
| Vydáno v: | One Health |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7784546/ https://ncbi.nlm.nih.gov/pubmed/33426262 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.onehlt.2021.100214 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|